Aspirin May Cut Colon Cancer Risk by 60 Percent

USA Today

Taking two aspirins a day reduced the risk of colorectal cancer by more than 60% in people with a family history of the disease, a large study shows.

"This is one more piece of evidence that there are some very positive effects of aspirin, and it should be considered very seriously for people who are at risk of colorectal cancer," says Tim Bishop, one of the authors of the study and a professor of epidemiology at Leeds University in England... Read More

Learn more about colon cancer treatment at the Abramson Cancer Center

Observational studies have shown that aspirin lowers the risk of developing colorectal cancer, but this is the first randomized controlled trial to find the effect.